Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/10593

N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide : a novel reversible antimitotic agent inhibiting cancer cell motility


Vista previa

Ver/Abrir:
 N-2_Aceves_BP_2016_postprint.pdf
3,07 MB
Adobe PDF
Título : N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide : a novel reversible antimitotic agent inhibiting cancer cell motility
Autor : Aceves Luquero, Clara
Galiana Roselló, Cristina
Ramis, Guillem
Villalonga Planells, Ruth
García España, Enrique
Fernández de Mattos, Silvia
Peláez, Rafael
Llinares, José M.
González Rosende, María Eugenia
Villalonga, Priam
Materias: Células cancerosas - Motilidad.Cancer cells - Motility.Mitosis.Sulfamidas - Uso terapéutico.Sulfonamides - Therapeutic use.Apoptosis.
Editorial : Elsevier
Citación : Aceves-Luquero, C., Galiana-Roselló, C., Ramis, G., Villalonga-Planells, R., García-España, E., Fernández de Mattos, S. et al. (2016). N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide : a novel reversible antimitotic agent inhibiting cancer cell motility. Biochemical Pharmacology, vol. 115, pp. 28-42. DOI: https://doi.org/10.1016/j.bcp.2016.06.016
Resumen : A series of compounds containing the sulfonamide scaffold were synthesized and screened for their in vitro anticancer activity against a representative panel of human cancer cell lines, leading to the identification of N-(2-methyl-1H-indol-5-yl)-1-naphthalenesulfonamide (8e) as a compound showing a remarkable activity across the panel, with IC50 values in the nanomolar-to-low micromolar range. Cell cycle distribution analysis revealed that 8e promoted a severe G2/M arrest, which was followed by cellular senescence as indicated by the detection of senescence-associated b-galactosidase (SA-b-gal) in 8e-treated cells. Prolonged 8e treatment also led to the onset of apoptosis, in correlation with the detection of increased Caspase 3/7 activities. Despite increasing c-H2A.X levels, a well-established readout for DNA double-strand breaks, in vitro DNA binding studies with 8e did not support interaction with DNA. In agreement with this, 8e failed to activate the cellular DNA damage checkpoint. Importantly, tubulin staining showed that 8e promoted a severe disorganization of microtubules and mitotic spindle formation was not detected in 8e-treated cells. Accordingly, 8e inhibited tubulin polymerization in vitro in a dose-dependent manner and was also able to robustly inhibit cancer cell motility. Docking analysis revealed a compatible interaction with the colchicine-binding site of tubulin. Remarkably, these cellular effects were reversible since disruption of treatment resulted in the reorganization of microtubules, cell cycle re-entry and loss of senescent markers. Collectively, our data suggest that this compound may be a promising new anticancer agent capable of both reducing cancer cell growth and motility.
Descripción : Este es el post-print que se ha publicado de forma definitiva en: https://www.sciencedirect.com/science/article/abs/pii/S0006295216301423
URI : http://hdl.handle.net/10637/10593
Derechos: http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
ISSN : 0006-2952
1873-2968 (Electrónico)
Fecha de publicación : 25-sep-2016
Centro : Universidad Cardenal Herrera-CEU
Aparece en las colecciones: Dpto. Farmacia





Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.